Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia
Top Cited Papers
- 3 June 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (21), 2677-2683
- https://doi.org/10.1161/01.cir.0000070540.80780.92
Abstract
Background— Catheter-based intracoronary vascular endothelial growth factor (VEGF) gene transfer is a potential treatment for coronary heart disease. However, only limited data are available about ...Keywords
This publication has 14 references indexed in Scilit:
- The VIVA TrialCirculation, 2003
- Hypothesis-Driven ScienceMolecular Therapy, 2002
- Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectorisCoronary Artery Disease, 2001
- Catheter-Mediated Vascular Endothelial Growth Factor Gene Transfer to Human Coronary Arteries after AngioplastyHuman Gene Therapy, 2000
- Cardiovascular gene therapyThe Lancet, 2000
- β-Galactosidase Gene Transfer to Human Malignant Glioma In Vivo Using Replication-Deficient Retroviruses and AdenovirusesHuman Gene Therapy, 1998
- Adenovirus-Mediated Gene Transfer to Lower Limb Artery of Patients with Chronic Critical Leg IschemiaHuman Gene Therapy, 1998
- VEGF Gene Transfer Reduces Intimal Thickening via Increased Production of Nitric Oxide in Carotid ArteriesHuman Gene Therapy, 1997
- Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomographyJournal of the American College of Cardiology, 1995
- Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgeryThe International Journal of Cardiovascular Imaging, 1994